The diagnostic value of serum DSA-TRF in hepatocellular carcinoma

被引:0
|
作者
Wenqian Guan
Zhiyuan Gao
Chenjun Huang
Meng Fang
Huijuan Feng
Shipeng Chen
Mengmeng Wang
Jun Zhou
Song Hong
Chunfang Gao
机构
[1] Shanghai Eastern Hepatobiliary Surgery Hospital,Department of Laboratory Medicine
[2] Fujian Medical University,Clinical Medical College
[3] Medical School of Nanjing University,Department of Emergency Medicine, Jinling Hospital
来源
Glycoconjugate Journal | 2020年 / 37卷
关键词
Transferrin; Hepatocellular carcinoma; Glycan biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
TRF is a glycoprotein mainly secreted by hepatocytes, The aim of this study was to explore the diagnostic value of aberrant glycosylated serum transferrin (TRF) especially containing multi-antennary glycans in hepatocellular carcinoma (HCC).A total of 581 subjects including HCC patients, liver cirrhosis (LC) patients, chronic hepatitis (CHB) patients and healthy controls (HC) were recruited. All the subjects were randomly assigned to training group (n = 411) and validation group (n = 170). We firstly analyzed the serum protein N-glycome profiling of HCC, LC, and HC by DNA sequencer–assisted fluorophore-assisted carbohydrate electrophoresis (DSA-FACE) technology. We established a lectin-antibody sandwich ELISA (Lectin-ELISA) method to detect multi-antennary glycans-contained TRF (DSA-TRF) in serum, in which Datura stramonium Agglutinin (DSA) was used for specific recognition. Levels of serum DSA-TRF and TRF were analyzed respectively. The diagnostic efficacies of DSA-TRF and TRF of differentiating HCC patients from CHB, LC patients and HC within the training group were evaluated using receiver operating characteristic (ROC) curve and tested in the validation group.The result found that in training group, serum TRF and DSA-TRF levels differed significantly between HCC (1.86 ± 0.50, g/L, 0.285 ± 0.06), CHB + LC (2.39 ± 0.74, g/L, 0.189 ± 0.07) and HC (1.92 ± 0.69, g/L, 0.249 ± 0.09) (HCC vs. CHB + LC, P < 0.001; HCC vs. HC, P < 0.001; CHB + LC vs. HC, P < 0.001). The area under the ROC curve (AUC) of DSA-TRF was significantly superior to AFP (0.880, 95%CI: 0.834–0.925 vs. 0.776, 95%CI: 0.725–0.827, P = 0.003) in differentiating HCC from CHB + LC. The AUC of diagnostic model GlycoTRF1 (0.981, 95%CI: 0.969–0.993) was higher than DSA-TRF and AFP alone (P<0.001) in differentiating HCC from CHB + LC, which was verified in validation group.The results indicated that the serum DSA-TRF might serve as a potential glycan biomarker for distinguishing HCC from CHB and LC.
引用
收藏
页码:231 / 240
页数:9
相关论文
共 50 条
  • [31] The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients
    Xu, Fei
    Zhang, Lulu
    He, Wenting
    Song, Di
    Ji, Xiaomeng
    Shao, Jianyong
    DISEASE MARKERS, 2021, 2021
  • [32] Diagnostic value of CD34 expression in hepatocellular carcinoma
    Ohmori, S
    Shiraki, K
    Sugimoto, K
    Murata, K
    Nakano, T
    JOURNAL OF HEPATOLOGY, 2005, 42 : 99 - 99
  • [33] Diagnostic value of imaging examinations in patients with primary hepatocellular carcinoma
    Li, Xing-Hui
    Liang, Qi
    Chen, Tian-Wu
    Wang, Jian
    Zhang, Xiao-Ming
    WORLD JOURNAL OF CLINICAL CASES, 2018, 6 (09) : 242 - 248
  • [34] Diagnostic value of imaging examinations in patients with primary hepatocellular carcinoma
    Xing-Hui Li
    Qi Liang
    Tian-Wu Chen
    Jian Wang
    Xiao-Ming Zhang
    World Journal of Clinical Cases, 2018, (09) : 242 - 248
  • [35] Diagnostic value of color Doppler ultrasonography in hepatocellular carcinoma.
    Goral, V
    Mumbuc, L
    Bilici, A
    Kemaneci, A
    GASTROENTEROLOGY, 1997, 112 (04) : A1273 - A1273
  • [36] Diagnostic and prognostic value of plasma fibrinolytic markers in hepatocellular carcinoma
    Ho, CH
    Chau, WK
    Chao, Y
    Lee, SD
    King, KL
    Wu, CW
    Liu, SM
    ADVANCES IN THERAPY, 1998, 15 (02) : 98 - 105
  • [37] Serum chromogranin-A in hepatocellular carcinoma: Diagnostic utility and limits
    Spadaro, Aldo
    Ajello, Antonino
    Morace, Carmela
    Zirilli, Agata
    D'arrigo, Graziella
    Luigiano, Carmelo
    Martino, Francesco
    Bene, Anna
    Migliorato, Domenico
    Turiano, Santi
    Ferrau, Oscar
    Freni, Maria Antonietta
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (13) : 1987 - 1990
  • [38] Serum chromogranin-A in hepatocellular carcinoma: Diagnostic utility and limits
    Aldo Spadaro
    Antonino Ajello
    Carmela Morace
    Agata Zirilli
    Graziella D’arrigo
    Carmelo Luigiano
    Francesco Martino
    Anna Bene
    Domenico Migliorato
    Santi Turiano
    Oscar Ferraù
    Maria Antonietta Freni
    World Journal of Gastroenterology, 2005, (13) : 1987 - 1990
  • [39] SERUM ANGIOPOIETIN 2 AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN HEPATOCELLULAR CARCINOMA
    Chiba, Tetsuhiro
    Ao, Junjie
    Kanzaki, Hiroaki
    Ma, Yaojia
    Iwanaga, Terunao
    Sakuma, Takahumi
    Kan, Motoyasu
    Fujita, Naoto
    Koroki, Keisuke
    Kanayama, Ken Go
    Kobayashi, Kazuhumi
    Nakamura, Masato
    Kanogawa, Naoya
    Kiyono, Soichiro
    Kondo, Takayuki
    Saito, Tomoko
    Ogasawara, Sadahisa
    Ooka, Yoshihiko
    Suzuki, Eiichiro
    Nakamoto, Shingo
    Nakagawa, Ryo
    Muroyama, Ryosuke
    Kato, Naoya
    HEPATOLOGY, 2020, 72 : 685A - 686A
  • [40] DIAGNOSTIC EVALUATION OF SERUM-LIPIDS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    YOSHIDA, T
    OKAZAKI, N
    YOSHINO, M
    ARAKI, E
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1977, 7 (01) : 15 - 20